Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

10.5K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.5K
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.0K
Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

1.5K
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
1.5K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.9K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.9K
Trial and Error and Algorithm01:12

Trial and Error and Algorithm

420
A problem-solving strategy is a plan of action used to find a solution. Different strategies have distinct action plans. Trial and error involves trying different solutions until one works. For instance, to fix a broken printer, you might check ink levels, ensure the paper tray isn't jammed, and verify the printer's connection to your laptop. This method can be time-consuming but is commonly used. Thomas Edison, for example, used trial and error to find a suitable filament for the light...
420
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

783
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
783

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Route of Allergen Immunotherapy: A Global Look Into Physicians' Motivations.

Allergy·2026
Same author

Two cases of severe apple-induced reactions and sensitization to gibberellin-regulated proteins: A diagnostic challenge.

Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology·2026
Same author

Managing Renewed Food Avoidance Following an Allergic Reaction for Patients With Avoidant/Restrictive Food Intake Disorder.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

'What' and 'How' to Measure in Allergy and Clinical Immunology: A Systematic Review of Core Outcome Sets and Outcome Harmonisation Processes.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2026
Same author

Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving Forward.

Allergy·2026
Same author

Clinical outcomes in food allergy: Implications for patients, clinicians, and health systems.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026

Related Experiment Video

Updated: Feb 3, 2026

RNAi-mediated Control of Aflatoxins in Peanut: Method to Analyze Mycotoxin Production and Transgene Expression in the Peanut/Aspergillus Pathosystem
09:44

RNAi-mediated Control of Aflatoxins in Peanut: Method to Analyze Mycotoxin Production and Transgene Expression in the Peanut/Aspergillus Pathosystem

Published on: December 21, 2015

21.5K

Evaluating primary end points in peanut immunotherapy clinical trials.

Pablo Rodríguez Del Río1, Carmelo Escudero1, Silvia Sánchez-García1

  • 1Allergy Department, Hospital Infantil Universitario Niño Jesús, Madrid, Spain; Health Research Institute Princesa, Madrid, Spain; ARADyAL RD16/0006/0026, Madrid, Spain.

The Journal of Allergy and Clinical Immunology
|October 28, 2018
PubMed
Summary

Food immunotherapy, particularly for peanut allergy, shows promise for future clinical use. Understanding treatment efficacy and endpoint measurement is crucial for allergists due to trial variations.

Keywords:
Peanut allergydesensitizationfood allergyfood immunotherapyoral food challengerandomized clinical trialsustained unresponsiveness

More Related Videos

In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus
10:24

Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus

Published on: April 19, 2024

1.7K

Related Experiment Videos

Last Updated: Feb 3, 2026

RNAi-mediated Control of Aflatoxins in Peanut: Method to Analyze Mycotoxin Production and Transgene Expression in the Peanut/Aspergillus Pathosystem
09:44

RNAi-mediated Control of Aflatoxins in Peanut: Method to Analyze Mycotoxin Production and Transgene Expression in the Peanut/Aspergillus Pathosystem

Published on: December 21, 2015

21.5K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.3K
Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus
10:24

Author Spotlight: Quantification of Aflatoxins and Phytoalexins in Peanut Seeds to Identify Genetic Resistance Against Aspergillus

Published on: April 19, 2024

1.7K

Area of Science:

  • Allergy and Immunology
  • Clinical Therapeutics
  • Pharmaceutical Development

Background:

  • Food immunotherapy is a rapidly evolving area of allergy research.
  • Promising early-stage results are driving pharmaceutical interest in commercial products, especially for peanut allergy.
  • Allergists need to understand emerging treatments, their efficacy, and adverse event profiles.

Purpose of the Study:

  • To clarify the definition and assessment of primary efficacy endpoints in food immunotherapy trials.
  • To facilitate understanding of trial designs and the impact of endpoint variation on reported outcomes.
  • To prepare allergists for the clinical integration of new food immunotherapy treatments.

Main Methods:

  • Analysis of primary efficacy endpoints across diverse food immunotherapy clinical trials.
  • Examination of how different endpoint definitions and measurement strategies are employed.
  • Review of literature to identify heterogeneity in trial methodologies.

Main Results:

  • Significant heterogeneity exists among food immunotherapy trials regarding endpoint definition and assessment.
  • Variations in endpoints can impact the interpretation of treatment efficacy and reported outcomes.
  • Standardization of endpoints is challenging but essential for comparing trial results.

Conclusions:

  • A clear understanding of endpoint variations is critical for allergists evaluating food immunotherapy evidence.
  • Consistent endpoint measurement is needed to accurately assess the efficacy of emerging treatments.
  • Further research should focus on standardizing outcome measures in food immunotherapy studies.